1Nilsson U. Effectiveness of music interventions for women with high anxiely during coronary angiographic procedures: a randomized controlled. Eur J Cardiovasc Nurs,2012,11 : 150-153.
2Schnapf AJ. Prasugrel versus clopidogrel : New management strategies for acute coronary syndrome. J Cardiovasc Nurs. 2012VNJ Cardiovasc Nurs, 2012,9:2032-2299.
3Manoukian SV, Voeltz MD,Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention:predictors, prognostic signficance, and paradigms for reducing risk. Clin Cardiol, 2007,30 : 1124-1134.
4Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol, 2005,96 : 173-176.
5Feit F, Vocltz MD, Attubato M J, et al. Predictors and impact of major hemorrhage on mortality following pcrcutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol,2007,100:1364-1369.
6Chin MW, Yong G, Bulsara MK, et al. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol, 2007,102 : 2411-2416.
3Arzu E, Emre AR, Mehmet K, Selim Y, Necmi D. Percutaneous coronary intervention in left main coronary artery disease in a patient with hemophilia B. Cardiovasc Interv Ther 2011; 26: 153-156.
4Vosbergen S, Janzen J, Stappers PJ, et al. A qualitative participatory study to identify experiences of coronary heart disease patients to support the development of online self-management services. Int J Med Inform, 2013,82(12):1183-1194.
5Mondal C, Halder AK, Adhikari N, et al. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2- propanols. Comput Biol Med, 2013,43(10): 1545-1555.
